squaric acid dibutyl ester has been researched along with Cold Sore in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, ALS; Dudek, AZ; Guan, L; Honari, G; Horn, TD; McTavish, H; Palli, MA; Zhao, L | 1 |
| Kren, BT; Matson, MA; McTavish, H; Shekels, LL; Zeller, JC; Zerebiec, KW | 1 |
1 trial(s) available for squaric acid dibutyl ester and Cold Sore
| Article | Year |
|---|---|
A phase 2, multicenter, placebo-controlled study of single-dose squaric acid dibutyl ester to reduce frequency of outbreaks in patients with recurrent herpes labialis.
Topics: Adjuvants, Immunologic; Administration, Topical; Cyclobutanes; Double-Blind Method; Drug Administration Schedule; Herpes Labialis; Herpesvirus 1, Human; Humans; Placebos; Recurrence; Secondary Prevention; Severity of Illness Index; Symptom Flare Up; Treatment Outcome | 2020 |
1 other study(ies) available for squaric acid dibutyl ester and Cold Sore
| Article | Year |
|---|---|
Immune characteristics correlating with HSV-1 immune control and effect of squaric acid dibutyl ester on immune characteristics of subjects with frequent herpes labialis episodes.
Topics: Adolescent; Adult; Antiviral Agents; Candida; Cyclobutanes; Female; Gene Expression Regulation; Herpes Labialis; Herpes Simplex; Herpesvirus 1, Human; Humans; Interferon-gamma; Interleukin-5; Leukocytes, Mononuclear; Male; Middle Aged; Recurrence; Young Adult | 2019 |